Pharmacy-Led Management of Atrial Fibrillation: Improving Treatment Adherence and Patient Outcomes

被引:1
|
作者
Veale, Emma L. [1 ,2 ]
机构
[1] Univ Kent, Medway Sch Pharm, Chatham, Kent, England
[2] Univ Greenwich, Chatham Maritime, Chatham, Kent, England
关键词
atrial fibrillation; oral anticoagulants; pharmacists; medication adherence; stroke; long-term conditions; ORAL ANTICOAGULATION THERAPY; ANTITHROMBOTIC THERAPY; ELDERLY-PATIENTS; RISK-FACTORS; HEALTH-CARE; STROKE PREVENTION; MEDICAL-TREATMENT; FOCUSED UPDATE; PREFERENCES; PREVALENCE;
D O I
10.2147/IPRP.S397844
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The world's population is ageing, with the number of those over 60 years expected to represent a fifth of the total population by 2050. Increases in chronic long-term health conditions (LTCs) associated with ageing, and requiring regular but often avoidable medical intervention, are pressurising already overloaded, health and social care systems. Atrial fibrillation (AF) is an LTC, which is most frequently diagnosed in the elderly. An often, asymptomatic condition, AF is associated with a 3- to 5-fold increased risk of severe ischemic stroke. Stroke prevention, with risk-stratified oral anticoagulants (OACs) is the standard recommended care for patients with AF. Stroke avoidance is, however, dependent on persistent adherence to OAC medication, with an adherence rate of >80% considered necessary to achieve optimal health outcomes. Suboptimal adherence to OACs is common, with a third of all AF patients not taking their medication as prescribed. This combined with the short half-life of OACs can result in poor clinical outcomes for patients. Policy makers now consider improving adherence to prescribed medicines for LTCs, a public health priority, to ensure better health outcomes for patients, whilst minimising unnecessary health system costs. Prescribing medicines to treat LTCs, such as AF, is not enough, particularly when the patient may not experience any measurable benefit to the treatment and may instead, experience medication-associated adverse events, including a risk of bleeding. Pharmacists who are experts in medicines management are ideally placed to support medication adherence, to educate, and to improve health outcomes for patients with AF. In this review, I will consider the evidence for poor medication adherence in LTCs and in particular adherence to OACs in patients with AF and highlight the role that pharmacists can play in ensuring optimal adherence and showcase pharmacist-led interventions that effectively address this problem.
引用
收藏
页码:101 / 114
页数:14
相关论文
共 50 条
  • [1] MEDICATION ADHERENCE AMONG PATIENTS IN A PHARMACY-LED CLINICAL MANAGEMENT PROGRAM FOR CYSTIC FIBROSIS
    Kirkham, H. S.
    Mclane, D. P.
    Staskon, F. C.
    DuChane, J.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 285 - 285
  • [2] AN EVALUATION OF A PHARMACY-LED MEDICATION MANAGEMENT PROGRAM TO IMPROVE PHARMACY PERFORMANCE
    Desai, R. A.
    Turner, K.
    Shea, C.
    VALUE IN HEALTH, 2019, 22 : S325 - S325
  • [3] Patient Outcomes According to Adherence to Treatment Guidelines for Rhythm Control of Atrial Fibrillation
    Qin, Dingxin
    Leef, George
    Alam, Mian Bilal
    Rattan, Rohit
    Munir, Mohamad Bilal
    Patel, Divyang
    Khattak, Furqan
    Vaghasia, Nishit
    Adelstein, Evan
    Jain, Sandeep K.
    Saba, Samir
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (04):
  • [4] Clinical Outcomes of a Pharmacy-Led Blood Factor Stewardship Program
    Trueg, Anne O.
    Lowe, Christopher
    Kiel, Patrick J.
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (06) : e643 - e647
  • [5] Patients' experiences of a community pharmacy-led medicines management service
    Bissell, Paul
    Blenkinsopp, Alison
    Short, Duncan
    Mason, Linda
    HEALTH & SOCIAL CARE IN THE COMMUNITY, 2008, 16 (04) : 363 - 369
  • [7] Impact of a Pharmacy-Led Transition of Care Service on Post-Discharge Medication Adherence
    Stroud, Alaina
    Adunlin, Georges
    Skelley, Jessica W.
    PHARMACY, 2019, 7 (03)
  • [8] Clinical pharmacy-led disease and medicine management programme for patients with COPD
    Khdour, Maher R.
    Kidney, Joseph C.
    Smyth, Bronagh M.
    McElnay, James C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (04) : 588 - 598
  • [9] Pharmacy-led hepatitis C treatment pathways to help ensure elimination
    Gunn, Jack
    Higgs, Peter
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (01): : 12 - 13
  • [10] Students as catalysts to increase community pharmacy-led direct patient care services
    Rodis, Jennifer L.
    Ulbrich, Timothy R.
    Jennings, Brandon T.
    Elswick, Betsy M.
    McKinley, Rebekah Jackowski
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2015, 55 (06) : 642 - 648